CombiGene – the gene therapy explorer
The goal for CombiGene is to develop treatment methods that can improve
the lives of milions of people all over the world.
Latest news from CombiGene
Read, among other things, how CombiGene takes the next big step towards clinical trials
Final data from long-term study of CombiGene’s epilepsy treatment indicate clearly positive effects in the form of fewer and shorter seizures.
Final data from CombiGene’s preclinical proof-of-concept-study (the long-term study) show that CombiGene’s candidate drug, CG01, has clear antiepileptic effects. The study has demonstrated that CG01 reduces the frequency and duration of epileptic seizures...
CombiGene establishes UK subsidiary to secure close and effective collaboration with Cell and Gene Therapy Catapult
Developing new treatment methods for neurological diseases, with higher precision, greater efficacy and fewer side effects.
A STEP BY STEP TREATMENT
The focus for CombiGene is to produce a therapy for epileptic patients who cannot be helped by available medical treatments at present.
Read more »